title: Successful discontinuation of eculizumab therapy in a patient with aHUS.
authors.affiliation: Penn State Hershey Cancer Institute, Penn State Hershey Medical Center, Penn State University College of Medicine, 500 University Drive, Hershey, PA, 17033, USA, jpu2@jhmi.edu.
authors.forename: Jeffrey J
authors.initials: JJ
authors.lastname: Pu
authors.forename: Abigail
authors.initials: A
authors.lastname: Sido
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology / Q000628:therapy; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use*; D065766:Atypical Hemolytic Uremic Syndrome; D016470:Bacteremia / Q000150:complications / Q000188:drug therapy; D003131:Combined Modality Therapy; D003170:Complement Pathway, Alternative; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D006801:Humans; D022401:Meningococcal Vaccines; D010951:Plasma Exchange; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy; D006435:Renal Dialysis
chemical_list: D000900:Anti-Bacterial Agents; D061067:Antibodies, Monoclonal, Humanized; D022401:Meningococcal Vaccines; C481642:eculizumab